Severe Pulmonary Hypertension in Liver Transplant Candidates
Ramsay et al. Liver Transplantation and Surgery, Vol 3 No 5 (Sept),
1997: 494-500.
Reviewed by: R. Prasad, MD
Comments:
-
Large series of patients, althouth only 12 with severe PHTN.
-
Using mean PAP would be better than systolic PAP - less subject to artifact.
Summary:
-
Reviewed 1205 consecutive OLTs at Baylor, 12/84-10/95.
-
PHTN defined as mean PAP >=25, and PVR>120)
-
PHTN incidence 8.5%: 81 mild, 14 moderate, 7 severe (+5 others with severe
PHTN who died during evaluation or not candidates).
-
12 severe = 9 primary PHTN + 3 mixed pathology (PPHTN, hepatorenal syndrome
with volume overload, secondary cardiac dysfnct).
-
Despite initially doing well after OLT, PHTN did not resolve in most with
severe PHTN.
|
Severity
|
PAS
|
36mo % Mortality
|
|
None
|
<30
|
20-28 ?
|
|
Mild
|
30-44
|
33
|
|
Mod
|
45-59
|
35
|
|
Sev
|
60+
|
71
|
Their recommendations:
-
Reversible P HTN = positive response (20-30% dec in PVR and mean PAP) to
vasodilator (PGE1 often used; also, nifedipine, NO occasionally).
-
Suggests improved survival, with decreased PAP after OLT.
-
Irreversible PHTN suggests low likelighood that OLT will reverse PHTN.
-
PPHTN-associated-mortality may best correllate with RV fnct, as well as
mean PAP. Good RV fnct + moderate PHTN = good chance of survival.
-
Monitor OLT candidates with q3mo echo.
-
Cancel OLT if mean PAP>45 that is not reversible with pulm vasodilators.
Home-Amb-Card-Crit-Neuro-OB-Orth-Pain-Ped-Reg-Tran-Vasc-Misc